China’s Healthcare Sector Set for Foreign Investment Explosion
This article was originally published in PharmAsia News
Executive Summary
Foreign Direct Investment (FDI) into China's life sciences sector will increase by 177% to £128.2 billion by 2020, as the rapidly ageing population drives demand for healthcare services and the Chinese government makes efforts to relax controls. So says a new report from global law firm King & Wood Mallesons, Branching Out: Investment Opportunities in China in 2020.